| Literature DB >> 15929902 |
William Beckett1, Michael Kallay, Akshay Sood, Zhengfa Zuo, Donald Milton.
Abstract
A previously healthy man working as a machine operator in an automotive factory developed respiratory symptoms. Medical evaluation showed abnormal pulmonary function tests, a lung biopsy showed hypersensitivity pneumonitis, and his illness was traced to his work environment. His physician asked the employer to remove him from exposure to metalworking fluids. Symptoms reoccurred when he was later reexposed to metalworking fluids, and further permanent decrement in his lung function occurred. Investigation of his workplace showed that five of six large reservoirs of metalworking fluids (cutting oils) grew Mycobacterium chelonae (or Mycobacterium immunogenum), an organism previously associated with outbreaks of hypersensitivity pneumonitis in automaking factories. His lung function remained stable after complete removal from exposure. The employer, metalworking fluid supplier, union, and the National Institute for Occupational Safety and Health were notified of this sentinel health event. No further cases have been documented in this workplace.Entities:
Mesh:
Year: 2005 PMID: 15929902 PMCID: PMC1257604 DOI: 10.1289/ehp.7727
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1In a process similar to that used by the patient, metalworking fluid (milky appearance) is flowed over auto parts to reduce friction and cool metal tools. As fluids are sprayed over metal parts, a visible aerosol is formed that can be breathed by operators of the machinery unless specific control measures are instituted. Fluids are recycled from large holding tanks. The presence of carbon and water in fluids permits growth of microorganisms, including mycobacteria.
Patient’s pulmonary function laboratory data.
| O2 saturation (%)
| ||||||
|---|---|---|---|---|---|---|
| Date | FEV1 (%) | FVC (%) | DLCO (%) | Rest | Exercise | Notes |
| June 1985 | 2.70 (88) | 3.0 (70) | — | — | — | Preplacement work exam before onset of symptoms |
| January 1996 | 2.77 (94) | 3.47 (95) | — | — | — | After onset of symptoms; spirometry before the work week |
| January 1996 | 2.98 (101) | 3.40 (93) | — | — | — | After shift at end of work week |
| September 1997 | — | — | — | 96 | 96 | — |
| January 1998 | — | — | (67) | — | — | — |
| April 2000 | 2.52 (89) | 3.14 (89) | 9.8 (44) | 92 | 89 | More symptomatic |
| June 2000 | 1.86 (60) | 2.55 (65) | — | — | — | — |
| April 2004 | 2.42 (89) | 3.15 (92) | 11.5 (45) | — | — | Symptoms stable |
Abbreviations: —, not measured; DLCO, diffusing capacity for carbon monoxide (percent predicted); FEV1, forced expiratory volume in 1 sec in liters (percent predicted); FVC, forced vital capacity in liters (percent predicted).
Figure 2Transbronchial biopsy specimen of the patient’s lung showing marked alveolar inflammation and cell proliferation with the presence of inflammatory and epithelioid cells.
Figure 3Thin-section CT scan of the chest showing ground glass opacities in the lung parenchyma, indicating interstitial inflammation and/or fibrosis.